Table 2.
BM (g) | TAT (g) | |||
---|---|---|---|---|
d 0 | d 41 | d 0 | d 41 | |
CH-Intact | 226 ± 6 | 298 ± 9### | 18 ± 1 | 33 ± 4## |
CH-OVX | 226 ± 6 | 357 ± 10*+ | 19 ± 1 | 51 ± 2*+ |
CH-OVX+E2 | 226 ± 7 | 281 ± 7 | 20 ± 1 | 34 ± 3 |
EN-Intact | 226 ± 7 | 363 ± 7* | 19 ± 1 | 84 ± 4* |
EN-OVX | 229 ± 7 | 399 ± 19+ϕ | 18 ± 2 | 95 ± 10 |
EN-OVX+E2 | 233 ± 8 | 356 ± 14 | 20 ± 1 | 83 ± 7 |
Initial (d 0) and final (d 41) body mass (BM) and total adipose tissue (TAT) mass, determined with microCT, of chow- and Ensure-fed intact rats (CH-Intact and EN-Intact), ovariectomized rats (CH-OVX and EN-OVX), and estradiol-treated ovariectomized rats (CH-OVX+E2 and EN-OVX+E2), means ± SEM. Initial and final levels in CH-Intact rats were compared with t-tests to characterize normal maturational changes. Group differences on d 41 were analyzed by planned comparisons, with experiment-wide significance P < 0.05, as described in the text.
#Different from d 0, P < 0.05, ##P < 0.01, ###P < 0.001;
*Different from CH-Intact;
+OVX different from OVX+E2, same diet group;
ϕEN-OVX different from EN-Intact.